IND Swift Limited Clarithromycin Export Data — India (DGFT 2022–2026)

Name: IND Swift Limited Clarithromycin Export Records India — #10 Exporter, 124 Shipments, $2.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Clarithromycin

India Pharmaceutical Trade Intelligence

$98.4M334 Suppliers144 CountriesHS 30042063

ExportsIndia → UNITED KINGDOM18.6%India → BELGIUM11.6%

ImportsUNITED STATES → India$112.9K ROMANIA → India$7.6K

#1 Supplier: MICRO LABS #1 Buyer: BROWN AND

IND Swift Limited — Clarithromycin Exporter #10 | $2.9M Trade Value | TransData Nexus | TransData Nexus

IND Swift Limited — Clarithromycin Exporter Profile

Indian Pharmaceutical Exporter · #10 for Clarithromycin · $2.9M export value · DGFT Verified

IND Swift Limited is the #10 Indian exporter of Clarithromycin with $2.9M in export value and 124 verified shipments. IND Swift Limited holds a 2.9% market share in Clarithromycin exports across 23 countries. The company exports 13 pharmaceutical products worth $36.7M across 9 therapeutic categories.

IND Swift Limited — Clarithromycin Export Profile: Buyers & Destinations

IND Swift Limited Clarithromycin export treemap — buyers and destination countries | TransData Nexus

Where Does IND Swift Limited Export Clarithromycin?

Country	Value	Shipments	Share
TANZANIA	$444.6K	20	18.6%
POLAND	$246.9K	6	10.4%
PHILIPPINES	$190.7K	5	8.0%
KENYA	$159.8K	10	6.7%

Who Are the Top Buyers of Clarithromycin from IND Swift Limited?

Buyer	Country	Value	Orders
DANANG PHARMACEUTICAL	VIETNAM	$263.1K	10
POLPHARMA SA	POLAND	$246.9K	6
PLANET PHARMACEUTICAL LTD.	TANZANIA	$214.4K	6
SURGIPHARM LIMITED	KENYA	$159.8K	10
PLANET PHARMACEUTICALS LTD.	TANZANIA	$148.1K	9
LIVLINA	BELGIUM	$144.3K	5
MORNINGSIDE PHARMACEUTICALS LIMITED	UNITED KINGDOM	$120.8K	5
NEW COUNTRY HEALTHCARE LLC	UNITED ARAB EMIRATES	$101.0K	4
UNILAB, INC.	PHILIPPINES	$91.3K	2
TCHAIKAPHARMA HIGH QUALITY	BULGARIA	$83.3K	4

IND Swift Limited supplies Clarithromycin to 36 buyers globally. The largest buyer is DANANG PHARMACEUTICAL (VIETNAM), followed by POLPHARMA SA (POLAND) and PLANET PHARMACEUTICAL LTD. (TANZANIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Clarithromycin Formulations Does IND Swift Limited Export?

Product Description / Formulation	Value	Shipments
KLABION UNO 500 MG(Clarithromycin Extend	$121.3K	3
CLARIE OD 500 MG(CLARITHROMYCIN EXTENDEDRELEASE TABLETS USP) BATCH NO.EV10524,EV10624,EV10724 MFG.05.04.2024 EXP.04.04.	$97.1K	3
SWIFT OD 500MG(CLARITHROMYCIN EXTENDED-R	$81.0K	2
CLARIE OD (CLARITHROMYCIN EXTENDED -RELEASE TABLETS USP ) B.N: EV12424 ,EV12524,MFG: DEC2024 EXP: NOV2028	$79.5K	2
CLARIE OD (CLARITHROMYCIN EXTENDED -RELEASE TABLETS USP ) B.N: EV12624,EV12724,MFG: DEC2024 EXP: NOV2028	$70.9K	2
CLARITHROMYCINE UNO EG 500MG TABSS(CLARI	$68.1K	2
CLARIE OD (CLARITHROMYCIN EXTENDED -RELEASE TABLETS USP ) BATCH NO: EV12523 MFG:DEC2023 EXP: NOV2027	$64.0K	2
CLARITHROMYCINE UNO EG 500 MG(CLARITHROM	$60.9K	2
KLACAR XL 500MG (CLARITHROMYCIN PROLONGED RELEASE TABLETS 500MG) BATCH NO WX10124, WX10224 MFG MAR2024 EXP FEB2028	$60.4K	3
CLOROM XL 500MG(CLARITHROMYCIN 500MG PROLONGED RELEASE TABLETS)B.NO.:TF10124 & TF10224 M:APR.2024 E:MAR.2027(29586X1X7T)	$51.8K	3

IND Swift Limited exports 74 distinct Clarithromycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is KLABION UNO 500 MG(Clarithromycin Extend with 3 shipments worth $121.3K.

How Does IND Swift Limited Compare to Nearest Clarithromycin Exporters?

Exporters ranked immediately above and below #10 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
4	CAPLIN POINT LABORATORIES LIMITED	$5.5M	110	10	$50.0K
7	AJANTA PHARMA LIMITED	$4.0M	109	9	$36.6K
10	IND SWIFT LIMITED ★	$2.9M	124	23	$23.0K
5	CIPLA LIMITED	$2.1M	43	6	$50.0K
6	WEXFORD LABORATORIES PRIVATE LIMITED	$1.8M	35	4	$50.0K

IND Swift Limited ranks #10 among 334 Indian Clarithromycin exporters. Average shipment value of $23.0K compared to the market average of $183.3K. The closest competitors by value are CAPLIN POINT LABORATORIES LIMITED and AJANTA PHARMA LIMITED.

Which Indian Ports Ship Clarithromycin Exports?

Port	Shipments	% Share
SAHAR AIR	365	10.2%
DELHI AIR CARGO ACC (INDEL4)	296	8.3%
SAHAR AIR CARGO ACC (INBOM4)	282	7.9%
DELHI AIR	258	7.2%
NHAVA SHEVA SEA (INNSA1)	229	6.4%
JNPT/ NHAVA SHEVA SEA	156	4.4%
JNPT	125	3.5%
DHANNAD ICD	124	3.5%

Geopolitical & Trade Policy Impact on IND Swift Limited's Clarithromycin Exports

Ind-Swift Laboratories' export operations have been influenced by recent geopolitical developments. The Israel-Iran conflict has heightened security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and increased freight rates by 40–50% on key India–Europe routes, impacting the company's logistics and cost structures. (livemint.com)

Conversely, the India–European Union Free Trade Agreement (India–EU FTA), concluded in January 2026, is poised to benefit Indian pharmaceutical exporters. The agreement eliminates tariffs on most European pharmaceutical imports, enhancing the competitiveness of Indian products in the EU market. This development presents an opportunity for Ind-Swift Laboratories to expand its footprint in Europe. (en.wikipedia.org)

In the United States, the reshoring of pharmaceutical manufacturing and potential imposition of tariffs on imports pose challenges for Indian exporters. While there are currently no import duties on Indian pharmaceutical products entering the US, the introduction of tariffs could affect the profitability of low-margin generic drugs, potentially leading to market exits. (cfo.economictimes.indiatimes.com)

IND Swift Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains paramount for Indian pharmaceutical exporters. Ind-Swift Laboratories has demonstrated a commitment to quality by adhering to Good Manufacturing Practices (GMP) as stipulated by the US FDA, WHO, and EU authorities. The company's manufacturing facilities in Punjab and Jammu have been inspected and approved by these regulatory bodies, facilitating access to regulated markets.

The evolving regulatory landscape, including the EU's Falsified Medicines Directive, necessitates continuous investment in quality systems and supply chain transparency. Ind-Swift Laboratories' focus on high-margin formulations underscores the importance of maintaining stringent quality standards to meet global regulatory requirements and sustain market access.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Clarithromycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: IND Swift Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 124 individual customs records matching IND Swift Limited exporting Clarithromycin, covering 74 formulations to 24 countries via 36 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 144+ countries, 811+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Clarithromycin

Clarithromycin

IND Swift Limited — Clarithromycin Exporter Profile

IND Swift Limited — Clarithromycin Export Profile: Buyers & Destinations

Where Does IND Swift Limited Export Clarithromycin?

Who Are the Top Buyers of Clarithromycin from IND Swift Limited?

What Is India's Total Clarithromycin Export Value and How Much Does IND Swift Limited Contribute?

What Is the Average Shipment Value for IND Swift Limited's Clarithromycin Exports?

How Does IND Swift Limited Compare to Other Indian Clarithromycin Exporters?

What Clarithromycin Formulations Does IND Swift Limited Export?

How Does IND Swift Limited Compare to Nearest Clarithromycin Exporters?

Which Indian Ports Ship Clarithromycin Exports?

Geopolitical & Trade Policy Impact on IND Swift Limited's Clarithromycin Exports

IND Swift Limited — Regulatory Compliance & Quality Standards

About IND Swift Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Clarithromycin Export Data from IND Swift Limited

Clarithromycin Stats

Company Overview

Top Products by IND Swift Limited

Related Analysis

Need Detailed Export Data?

Data Source